|
CN111646934A
|
|
Synthesis method of Nikemore
|
|
CN111481520A
|
|
Sitagliptin phosphate tablet
|
|
CN111606837A
|
|
Synthetic method of vildagliptin
|
|
CN111303033A
|
|
Preparation method of celecoxib
|
|
CN109125287A
|
|
A kind of Pregabalin tablet and preparation method thereof
|
|
CN109010837A
|
|
A kind of celecoxib composition with highly dissoluble
|
|
CN109172529A
|
|
A kind of E-0646 capsule preparations and preparation method thereof
|
|
CN109180761A
|
|
A kind of high-efficiency synthesis method of midecamycin acetate
|
|
CN108341821A
|
|
A kind of synthetic method of epinastine hydrochloride
|
|
CN108276330A
|
|
A kind of synthesis technology of Rebamipide
|
|
CN105001209A
|
|
Synthetic method of irbesartan
|
|
CN105017009A
|
|
Loxoprofen sodium synthesis method
|
|
CN105017226A
|
|
Trityl Losartan synthesis method
|
|
CN104447477A
|
|
Method for preparing sulpiride
|
|
CN104402802A
|
|
Method for preparing troxipide
|
|
CN104402873A
|
|
Preparation method of olmesartan medoxomil intermediate
|
|
CN104402757A
|
|
Preparation method of 2-(dimethylamino)-2-oxoethyl-2-(4-hydroxyphenyl) methyl acetate
|
|
CN104402800A
|
|
Preparation method for trans-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine
|
|
CN104402917A
|
|
Preparation method of novel ofloxacin intermediate
|
|
CN104447284A
|
|
Synthetic method of 2-(4-bromomethyl phenyl) propionic acid
|
